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012.07.0Abstract Aim of the work: To assess the relation between erectile dysfunction (ED) and the inci-
dence of the coronary artery disease (CAD) and its severity.
Patients and methods: We studied 80 patients {40 patients with CAD (patient group) and 40 per-
sons not known to have CAD (control group)}. For all patients full history including cardiac symp-
toms and International Index of Erectile Function 5 score (ILEF5) was taken. ED was considered
when ILEF5 score was 621. Coronary angiography was done to all patients and coronary lesion
P70% was considered signiﬁcant.
Results: ED was signiﬁcantly higher in patient group (18 cases, 45%) than control group (8 cases,
20%) {P-value = 0.017}. In most of the patients with ED (66.7%), the onset of ED occurred before
the onset of CAD. There was a signiﬁcant correlation between increase in the severity (decrease in
ED score) of ED and increase in the number of coronary vessel with signiﬁcant lesion (P
value = 0.001).
Conclusion: ED is frequently present in CAD patients and frequently comes before the onset of
CAD symptoms, representing an early warning sign for latent ischemic heart disease. Severity of
ED is related to severity of CAD.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.01006554042.
o.com (A.A. Youssef).
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051. Introduction
Previous studies have shown an increased incidence of erectile
dysfunction (ED) among patients diagnosed with coronary ar-
tery disease (CAD). The mechanism by which ED is linked to
CAD is endothelial dysfunction.1 Both conditions, share many
risk factors such as hypertension, dyslipidemia, diabetes,
depression, obesity, and cigarette smoking. In diabetic patients
ED is strongly associated with silent ischemic heart disease.
Because vascular disturbance of the penile endothelium leadsg by Elsevier B.V. All rights reserved.
94 A.A. Youssef et al.to ED, the possibility arises that ED may be an early indicator
for systemic endothelial dysfunction and subsequent CAD. ED
as a marker to increased cardiovascular risk may indicate the
need for aggressive evaluation for cardiovascular disease.1
The aim of our study is to assess the relation between ED
and the incidence of the CAD and its severity. We will assess
also ED as an early warning sign for CAD.
2. Patients and methods
We studied 80 patients: 40 patients with CAD (patient group)
and 40 persons not known to have CAD {normal coronaries
during routine diagnostic coronary angiography (35 persons)
or negative history, electrocardiogram (ECG) and stress
ECG ﬁndings for ischemia (5 persons)} (control group), se-
lected from the cardiology department, outpatient clinic of car-
diology and andrology in Assiut University Hospital. Four
persons (2 patients and 2 controls) refused penile duplex study.
Patients with cerebrovascular stroke, diabetes, hypertension,
previous pelvic surgery or radiation or penile congenital anom-
alies were excluded from our study.
Full history: including cardiovascular risk factors, presence
of chest pain, history of medications and full details about sex-
ual performance including International Index of Erectile
Function (ILEF5)2 was taken from all patients. ED was con-
sidered when ILEF5 score was 621.
IIEF-5 QUESTIONNAIRE2
The IIEF-5 score is the sum of the ordinal responses to the
ﬁve items; thus the score can range from 5 to 25.How do you rate your conﬁdence
that you could get and keep an
erection
Very low Low Moderate High Very high
When you had erections with
sexual stimulation, how often
were your erections hard enough
for penetration
Almost never/
never
Few times (much less
than half the times)
Sometimes
(about half the times)
Most times (much more
than half the times)
Almost
always/always
During sexual intercourse, how
often were you able to maintain
your erection after you had
penetrated your partner
Almost never/
never
Few times (much less
than half the times
Sometimes
(about half the times)
Most times (much more
than half the times)
Almost
always/always
During sexual intercourse, how
diﬃcult was it to maintain your
erection to completion of
intercourse
Extremely
diﬃcult
Very diﬃcult Diﬃcult Slightly diﬃcult Not diﬃcult
When you attempted sexual
intercourse, how often was it
satisfactory for you?
Almost never/
never
Few times (much less
than half the times
Sometimes
(about half the times)
Most times (much more
than half the times)
Almost
always/always
1 2 3 4 5Full physical examination: including palpation of lower
limb extremities pulsation, auscultation of carotid arteries for
murmurs, blood pressure measurement, cardiac examination
and full genital examination was also done.
ECG and stress ECG (when indicated), for signs of ische-
mia and echocardiography, for searching any segmental wall
abnormality and evaluation of left ventricular ejection fraction
were also done. We did coronary angiography: to assess the
presence or absence of coronary lesion and the number ofvessels affected. Coronary lesion P70% was considered
signiﬁcant.3
Patients with ED IIEF 5 score 6 21 were sent to andrology
clinic for further complete genital examination and investiga-
tion. Pharmaco-penile Duplex ultrasonography (PPDU) was
done by intracorporeal injection of prostaglandin E1 to evalu-
ate the arterial side by measurement of peak systolic velocity
(PSV) and also suggests the venous side by the end diastolic
velocity (EDV) after 5, 15 and 30 min. If PSV after 5 min is be-
low 35 cm/s this is with arterial insufﬁciency. If the EDV is
more than 5 cm/s it means venous leakage.
Statistics: Data were analyzed using SPSS software package
version 18. Quantitative data were expressed using range,
mean, standard deviation and median while qualitative data
were expressed in frequency and percent. Qualitative data were
analyzed using Chi-square test also exact tests such as Fisher
exact and Monte Carlo were applied to compare different
groups. Quantitative data were analyzed using student’s t-test
to compare between two groups. Spearman coefﬁcient was
used to analyze correlation between any two variables. P value
was assumed to be signiﬁcant at 0.05.3. Results
We studied 80 cases (40 patients have CAD and 40 controls).
Four cases (2 patients and 2 controls) refused to do penile
Duplex. There was no signiﬁcant difference between the age
of patient group that ranged 36–59 years with mean
47 ± 6.19 years and control group of 35–60 years with mean46 ± 7.2 years (Table 1). The ED was signiﬁcantly higher in
patient group (18 cases, 45%) than control group (8 cases,
20%) {P-value = 0.017} (Table 2). We found that the onset
of ED was 2–120 months with mean 23.9 ± 28 in patient
group while was 5–180 months with mean 48.6 ± 65 in control
(Table 2).
The relation between onset of ED and CAD in 12 patients
(66.7%) the onset of ED occurred before the onset of CAD
while in 5 patients (27.8%) the onset of ED occurred after
Table 1 Comparison between the different studied groups according to age.
Control (n= 40) Patients (n= 40) Test of sig.
No. % No. %
Age
<40 13 32.5 6 15.0 P= 0.211
40–50 17 42.5 21 52.5
>50 10 25.0 13 32.5
Range 35.0–60.0 36.0–59.0 P= 0.313
Mean ± SD 46.08 ± 7.20 47.60 ± 6.19
Median 47.0 48.0
Table 2 Comparison between the different studied groups according to erectile dysfunction (ED) (presence, score and onset).
Control (n= 40) Patients (n= 40) Test of sig.
No. % No. %
ED
No 32 80.0 22 55.0 p= 0.017
Yes 8 20.0 18 45.0
Score
Range 7.0–25.0 6.0–25.0 p= 0.006
Mean ± SD 22.10 ± 4.12 19.18 ± 5.08
Median 24.0 22.0
Onset of ED (n= 8) (n= 18)
Range 5.0–180.0 2.0–120.0 p= 0.449
Mean ± SD 48.6 ± 65.15 23.9 ± 28.25
Median 18.0 12
ED
12
66.7%
IHD
5
27.8%
ED & IHD
1
5.6%
Figure 1 Comparison between the different studied groups
according to onset of Erectile dysfunction and onset of Ischemic
heart diseases. ED = erectile dysfunction occurred before ische-
mic heart disease, IHD= ischemic heart disease occurred before
erectile dysfunction, ED and IHD= erectile dysfunction and
ischemic heart disease occurred at same time.
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Figure 2 Correlation between erectile dysfunction score and
number of vessels in patients with erectile dysfunction.
Erectile dysfunction as a predictive factorfor coronary artery disease 95CAD. In one patient both ED & IHD began at the same time
(Fig. 1).
The relation between ED occurrence and the left anterior
descending (LAD) lesion in patient group we found signiﬁcantLAD lesion in 10 (55%) of ED patients while 5 (28%) ED pa-
tients had no LAD lesion and 3 patients did not have coronary
angiography.
The correlation between score and number of coronary vessels
with signiﬁcant lesion there was signiﬁcant correlation between
increase in the severity (decrease in ED score) of ED and in-
crease in the number of coronary vessel with signiﬁcant lesion
(P value = 0.001) (Fig. 2).
The etiology of ED in our study in the patient group 5
(27.8%) had arterial insufﬁciency, 9 (50%) patients had
Table 3 Comparison between the different studied groups according to penile duplex.
Control (n= 8) Patients (n= 18) P value
No. % No. %
Penile of duplex
Arterial 2 25.0 5 27.8 1.000
Venous 1 12.5 1 5.6 0.529
Arterial and venous 2 25.0 9 50.0 0.395
Normal 1 12.5 1 5.6 0.529
Pt not do duplex 2 25.0 2 11.1 0.563
96 A.A. Youssef et al.arterial and venous, one (5.6%) patient had venous leakage
and other was normal. Two patients did not undergo penile
duplex. In the control group 2 (25%) persons had arterial
insufﬁciency, 2 (25%) had arterial and venous, 1 (12.5%)
had venous leakage and one had normal duplex. Two persons
did not undergo penile duplex (Table 3).
4. Discussion
Erectile dysfunction and cardiovascular disease share many
risk factors and their pathophysiology is mediated through
endothelial dysfunction.4,5 Cardiovascular diseases and their
risk factors increase the risk of ED, on the other hand ER
may be an early warning sign for future cardiovascular
events.1,6
We found ED in 45% of patient group and in 66.7% of
them the ED begins before the CAD. This agrees with
Gazzaruso et al.7 who, found that patients who developed ma-
jor adverse cardiac events over the course of approximately
47 months were more likely to have ED (61.2%) versus those
who did not (36.4%). This also agrees with Montorsi et al.8
who studied 300 consecutive unselected patients with angio-
graphically documented CAD. ED was detected in 49% of pa-
tients and in 67% of them ED preceded angina symptoms by a
mean interval of 34 months. Ma et al.9 found ED in 27% of
diabetic patients without clinical evidence of CAD. Over the
course of 4 years, they found that the incidence of CAD was
greater in ED patients than those without ED. Jackson et
al.10 said that the time interval among the onset of ED symp-
toms and the occurrence of CAD symptoms and cardiovascu-
lar events is estimated at 2–3 years and 3–5 years respectively;
this interval allows for risk factor reduction. Our results also
agree with Gazzaruso et al.11 who said that ED was signiﬁ-
cantly more prevalent in the CAD than in the NO CAD group
(37.8 versus 15.1%; P< 0.001) and was a predictor of asymp-
tomatic CAD.
So both CAD and ED conditions, which may be a conse-
quence of underlying endothelial dysfunction, share many risk
factors such as hypertension, dyslipidemia, diabetes, depres-
sion, obesity, and cigarette smoking. Because vascular distur-
bance of the penile endothelium leads to ED, the possibility
arises that ED may be an early indicator for systemic endothe-
lial dysfunction and subsequent CVD. Recognizing ED as a
disease marker for CVD may help to identify individuals at
risk for having a premature cardiovascular event.1 The occur-
rence of ER before CAD may be explained by the artery size
hypothesis, which suggests that larger vessels being able to bet-
ter tolerate the same amount of plaque compared with smaller
ones.8 Yao et al.12 said that the results of their study validatedthat subclinical endothelial dysfunction and low-grade inﬂam-
mation may be the underlying pathogenesis of ED with no
well-known etiology. Young patients complaining of ED
should be screened for cardiovascular risk factors and possible
subclinical atherosclerosis and they added that measurement
of ﬂow mediated vasodilatation, high sensitivity C-reactive
protein and Framingham risk score can improve our ability
to predict and treat ED, as well as subclinical cardiovascular
disease early for young male.
Ewane et al.13 concluded that the results showed a link be-
tween ED and the development of future CVD in some pa-
tients, but ED was not shown to be an independent risk
predictor that is any better than the traditional Framingham
risk factors. Screening for CVD may, however, be rewarding
in younger patients with severe ED and in patients with con-
current CVD risk factors.
Montorsi et al.14 found that IIEF-ED score was signiﬁ-
cantly lower in multi-vessel disease when compared with sin-
gle-vessel disease [18 (11.5–23) vs. 21 (16–24), P= 0.0069].
An inverse relationship was found between modiﬁed Gensini’s
score and IIEF score: R= 0.312, P< 0.0001. These ﬁndings
agree with our ﬁndings. We also found an inverse relationship
between the ED score and the number of coronary vessels with
signiﬁcant lesion (P= 0.001).
Our results also agree with Riedner et al.15 who concluded
that men with less than 60 years of age who report ED pre-
sented a higher risk of having chronic CAD and more severe
disease diagnosed by coronary angiography.
Limitations: The relatively fewer number of our patients
and the need to do this work at multi-centers on patients with
different risk factors to CAD.5. Conclusion
ED is frequently present in CAD patients and frequently
comes before the onset of CAD symptoms, representing an
early warning sign for latent ischemic heart disease. Severity
of ED is related to severity of CAD.
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